← Back to Search

Behavioral Intervention

Strategy training for Aphasia

N/A
Waitlist Available
Led By Sofia Vallila Rohter, PhD
Research Sponsored by MGH Institute of Health Professions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at 6 months
Awards & highlights

Study Summary

This trial will test whether combining semantic feature analysis treatment with metacognitive strategy training will help people with aphasia to use circumlocution across different contexts.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Naming accuracy
Strategy Knowledge
Strategy Use
Secondary outcome measures
Content Information Units

Trial Design

1Treatment groups
Experimental Treatment
Group I: Semantic Feature Analysis plus metacognitive strategy trainingExperimental Treatment1 Intervention
Participants attend three treatment sessions per week for eight weeks. Treatment sessions include: strategy education (participants learn about anomia, circumlocution, and circumlocution's purpose), Semantic Feature Analysis plus strategy application (participants build self-awareness and practice circumlocution), and strategy debriefing (participants reflect and receive feedback on their performance, and generate scenarios in which they could use the strategy in everyday life).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Strategy training
2021
N/A
~10

Find a Location

Who is running the clinical trial?

LSVT GlobalUNKNOWN
2 Previous Clinical Trials
2,010 Total Patients Enrolled
MGH Institute of Health ProfessionsLead Sponsor
15 Previous Clinical Trials
3,645 Total Patients Enrolled
2 Trials studying Aphasia
118 Patients Enrolled for Aphasia
Sofia Vallila Rohter, PhDPrincipal InvestigatorMGH Institute of Health Professions

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants still being enrolled in this research study?

"Clinicaltrials.gov confirms that this medical research is presently looking for participants. It was first made known on August 30th 2021 and the most recent update occurred on March 23rd 2022."

Answered by AI

What is the total recruitment number for participants in this clinical study?

"Indeed, the clinicaltrials.gov database shows that this investigation is currently looking for participants and was first advertised on August 30th 2021. Updated as recently as March 23rd 2022, it requests 20 patients from one site to take part in the trial."

Answered by AI

Are participants aged 45 years and above eligible for this clinical experiment?

"The enrolment parameters for this experiment necessitates that participants must range from 18 to 89 years old. Additionally, it contains 5 additional studies designed for minors and 86 experiments tailored towards senior citizens."

Answered by AI

What criteria must a person satisfy in order to take part in this exploration?

"In order to qualify, those with aphasia aged between 18 and 89 must apply. The maximum capacity of this trial is 20 individuals."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Incorporating Strategy Training Into Naming Treatment in Aphasia
Sofia Vallila Rohter 2021. "Incorporating Strategy Training Into Naming Treatment in Aphasia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05307796.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top